All Relations between Neuromyelitis Optica and oligodendrocyte

Publication Sentence Publish Date Extraction Date Species
Melania Spadaro, Edgar Mein. Detection of Autoantibodies Against Myelin Oligodendrocyte Glycoprotein in Multiple Sclerosis and Related Diseases. Methods in molecular biology (Clifton, N.J.). vol 1304. 2016-05-05. PMID:25814289. autoantibodies against myelin oligodendrocyte glycoprotein (mog) occur in a proportion of patients with different inflammatory demyelinating diseases of the central nervous system, such as childhood multiple sclerosis (ms), acute disseminated encephalomyelitis (adem), and neuromyelitis optica spectrum disorders (nmosd). 2016-05-05 2023-08-13 Not clear
Romana Höftberger, María Sepulveda, Thaís Armangue, Yolanda Blanco, Kevin Rostásy, Alvaro Cobo Calvo, Javier Olascoaga, Lluís Ramió-Torrentà, Markus Reindl, Julián Benito-León, Bonaventura Casanova, Georgina Arrambide, Lidia Sabater, Francesc Graus, Josep Dalmau, Albert Sai. Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease. Multiple sclerosis (Houndmills, Basingstoke, England). vol 21. issue 7. 2016-03-29. PMID:25344373. we aimed to report the frequency and implications of antibodies to myelin oligodendrocyte glycoprotein (mog-ab) in adults with demyelinating syndromes suspicious for neuromyelitis optica (nmo). 2016-03-29 2023-08-13 Not clear
Anne-Katrin Pröbstel, Gabrielle Rudolf, Klaus Dornmair, Nicolas Collongues, Jean-Baptiste Chanson, Nicholas S R Sanderson, Raija L P Lindberg, Ludwig Kappos, Jérôme de Seze, Tobias Derfus. Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype. Journal of neuroinflammation. vol 12. 2016-03-07. PMID:25889963. antibodies against myelin oligodendrocyte glycoprotein (mog) have been identified in a subgroup of pediatric patients with inflammatory demyelinating disease of the central nervous system (cns) and in some patients with neuromyelitis optica spectrum disorder (nmosd). 2016-03-07 2023-08-13 Not clear
Lukmanee Tradtrantip, Nithi Asavapanumas, Puay-Wah Phuan, A S Verkma. Potential therapeutic benefit of C1-esterase inhibitor in neuromyelitis optica evaluated in vitro and in an experimental rat model. PloS one. vol 9. issue 9. 2015-12-08. PMID:25191939. neuromyelitis optica (nmo) is an autoimmune demyelinating disease of the central nervous system in which binding of anti-aquaporin-4 (aqp4) autoantibodies (nmo-igg) to astrocytes causes complement-dependent cytotoxicity (cdc) and inflammation resulting in oligodendrocyte and neuronal injury. 2015-12-08 2023-08-13 human
Samira Saadoun, Patrick Waters, Gregory P Owens, Jeffrey L Bennett, Angela Vincent, Marios C Papadopoulo. Neuromyelitis optica MOG-IgG causes reversible lesions in mouse brain. Acta neuropathologica communications. vol 2. 2014-12-08. PMID:24685353. antibodies against myelin oligodendrocyte glycoprotein (mog-igg) are present in some neuromyelitis optica patients who lack antibodies against aquaporin-4 (aqp4-igg). 2014-12-08 2023-08-12 mouse
Mark Woodhall, Arzu Çoban, Patrick Waters, Esme Ekizoğlu, Murat Kürtüncü, Erkingul Shugaiv, Recai Türkoğlu, Gulsen Akman-Demir, Mefkure Eraksoy, Angela Vincent, Erdem Tüzü. Glycine receptor and myelin oligodendrocyte glycoprotein antibodies in Turkish patients with neuromyelitis optica. Journal of the neurological sciences. vol 335. issue 1-2. 2014-07-07. PMID:24045088. glycine receptor and myelin oligodendrocyte glycoprotein antibodies in turkish patients with neuromyelitis optica. 2014-07-07 2023-08-12 Not clear
Kevin Rostasy, Markus Reind. Role of autoantibodies in acquired inflammatory demyelinating diseases of the central nervous system in children. Neuropediatrics. vol 44. issue 6. 2014-07-01. PMID:24166146. the recent detection of aquaporin-4 (aqp4) and myelin oligodendrocyte glycoprotein (mog) autoantibodies in acquired inflammatory demyelinating diseases, such as neuromyelitis optica, or acute disseminated encephalomyelitis, and multiple sclerosis, in children strongly indicates that b-cell-dependent mechanisms contribute to the pathogenesis. 2014-07-01 2023-08-12 Not clear
Cecile Delarasse, Paul Smith, David Baker, Sandra Amo. Novel pathogenic epitopes of myelin oligodendrocyte glycoprotein induce experimental autoimmune encephalomyelitis in C57BL/6 mice. Immunology. vol 140. issue 4. 2014-04-18. PMID:23876060. myelin oligodendrocyte glycoprotein (mog), a minor protein of the central nervous system myelin, is recognized as a potential target in multiple sclerosis and neuromyelitis optica. 2014-04-18 2023-08-12 mouse
Douglas Kazutoshi Sato, Dagoberto Callegaro, Marco Aurelio Lana-Peixoto, Patrick J Waters, Frederico M de Haidar Jorge, Toshiyuki Takahashi, Ichiro Nakashima, Samira Luisa Apostolos-Pereira, Natalia Talim, Renata Faria Simm, Angelina Maria Martins Lino, Tatsuro Misu, Maria Isabel Leite, Masashi Aoki, Kazuo Fujihar. Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurology. vol 82. issue 6. 2014-04-01. PMID:24415568. to evaluate clinical features among patients with neuromyelitis optica spectrum disorders (nmosd) who have myelin oligodendrocyte glycoprotein (mog) antibodies, aquaporin-4 (aqp4) antibodies, or seronegativity for both antibodies. 2014-04-01 2023-08-12 Not clear
K Rostásy, S Mader, E M Hennes, K Schanda, V Gredler, A Guenther, A Blaschek, C Korenke, M Pritsch, D Pohl, O Maier, G Kuchukhidze, M Brunner-Krainz, T Berger, M Reind. Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica. Multiple sclerosis (Houndmills, Basingstoke, England). vol 19. issue 8. 2014-02-28. PMID:23257621. persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica. 2014-02-28 2023-08-12 Not clear
K Rostásy, S Mader, E M Hennes, K Schanda, V Gredler, A Guenther, A Blaschek, C Korenke, M Pritsch, D Pohl, O Maier, G Kuchukhidze, M Brunner-Krainz, T Berger, M Reind. Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica. Multiple sclerosis (Houndmills, Basingstoke, England). vol 19. issue 8. 2014-02-28. PMID:23257621. recently we showed that antibodies to myelin oligodendrocyte glycoprotein (mog) can be found in aquaporin-4 (aqp4)-immunoglobulin (igg) seronegative pediatric and adult patients with definite and high-risk neuromyelitis optica (nmo). 2014-02-28 2023-08-12 Not clear
Xiaoli Wu, Ming Zhou, Hui Ding, Shengli Xu, Chaodong Wang, Piu Cha. Myelin oligodendrocyte glycoprotein induces aquaporin-4 autoantibodies in mouse experimental autoimmune encephalomyelitis. Journal of neuroimmunology. vol 261. issue 1-2. 2013-10-17. PMID:23707078. to investigate whether aqp4 autoantibodies (aqp4-ab) are causative for neuromyelitis optica (nmo), the production of aqp4-ab and clinical experimental autoimmune encephalomyelitis (eae) was investigated in mice administered with mouse aqp4 antigen or myelin oligodendrocyte glycoprotein (mog35-55) alone, and in combination. 2013-10-17 2023-08-12 mouse
Yan Xu, Yao Zhang, Cai-yan Liu, Bin Peng, Jian-ming Wang, Xiao-jun Zhang, Hai-feng Li, Li-ying Cu. Serum antibodies to 25 myelin oligodendrocyte glycoprotein epitopes in multiple sclerosis and neuromyelitis optica: clinical value for diagnosis and disease activity. Chinese medical journal. vol 125. issue 18. 2013-02-13. PMID:22964310. serum antibodies to 25 myelin oligodendrocyte glycoprotein epitopes in multiple sclerosis and neuromyelitis optica: clinical value for diagnosis and disease activity. 2013-02-13 2023-08-12 Not clear
Simone Mader, Viktoria Gredler, Kathrin Schanda, Kevin Rostasy, Irena Dujmovic, Kristian Pfaller, Andreas Lutterotti, Sven Jarius, Franziska Di Pauli, Bettina Kuenz, Rainer Ehling, Harald Hegen, Florian Deisenhammer, Fahmy Aboul-Enein, Maria K Storch, Peter Koson, Jelena Drulovic, Wolfgang Kristoferitsch, Thomas Berger, Markus Reind. Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders. Journal of neuroinflammation. vol 8. 2012-07-31. PMID:22204662. complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders. 2012-07-31 2023-08-12 human
Xiaoli Guo, Chikako Harada, Kazuhiko Namekata, Kenji Kikushima, Yoshinori Mitamura, Hiroshi Yoshida, Yoh Matsumoto, Takayuki Harad. Effect of geranylgeranylacetone on optic neuritis in experimental autoimmune encephalomyelitis. Neuroscience letters. vol 462. issue 3. 2009-10-26. PMID:19616065. since it can cause irreversible visual loss, especially in the optic-spinal form of ms or neuromyelitis optica (nmo), the present study was conducted to assess the effects of geranylgeranylacetone (gga) on optic neuritis in the experimental autoimmune encephalomyelitis (eae) mouse model of ms. myelin oligodendrocyte glycoprotein-induced eae mice received oral administration of gga at 500 mg/kg or vehicle once daily for 22 days. 2009-10-26 2023-08-12 mouse
C Stadelmann, W Brüc. Lessons from the neuropathology of atypical forms of multiple sclerosis. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. vol 25 Suppl 4. 2005-04-18. PMID:15727225. devic's neuromyelitis optica may represent the prototypical disease with antibody/complement-mediated demyelination, whereas cases with balò's concentric sclerosis show oligodendrocyte dystrophy. 2005-04-18 2023-08-12 Not clear
C G Haase, S Schmid. Detection of brain-specific autoantibodies to myelin oligodendrocyte glycoprotein, S100beta and myelin basic protein in patients with Devic's neuromyelitis optica. Neuroscience letters. vol 307. issue 2. 2001-08-23. PMID:11427318. detection of brain-specific autoantibodies to myelin oligodendrocyte glycoprotein, s100beta and myelin basic protein in patients with devic's neuromyelitis optica. 2001-08-23 2023-08-12 Not clear